Skip to content
★ Sign in to follow
DM

David M. Kendall

Mannkind Corp
Total declarations
8
Company
1
▲ Purchases (5 ops.)
€20k
▼ Sales (0 ops.)
—

Latest filing published 04 Aug 2020 for Mannkind CORP, €4,255.

Filing timeline

BuySale
David M. Kendall

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
75%
Median T+90
+8.5%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 04 Aug 2020 · 2288 days ago · €4,255
    +125.8%
    Entry US$1.86 · Close at T+365 US$4.20
  • Filed 03 Feb 2020 · 2471 days ago · €1,985
    +241.3%
    Entry US$1.50 · Close at T+365 US$5.12
  • Filed 31 Jul 2019 · 2658 days ago · €4,290
    +33.3%
    Entry US$1.17 · Close at T+365 US$1.56
  • Filed 31 Jan 2019 · 2839 days ago · €4,657
    +11.9%
    Entry US$1.34 · Close at T+365 US$1.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David M. Kendall: trading record in brief

David M. Kendall is a declared insider of Mannkind Corp, with filings sourced from SEC (Form 4). The record holds 8 filings, for trades running from 14 November 2018 to 31 July 2020.

Every open-market trade on record is a purchase: 5 purchases worth €20k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. Since January 2020: 2 purchases and no sales on the market.

Half of the purchases are above €4,290 and half below. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +8.5%. This is a record of the past, not a forecast.

The record was last updated on 4 August 2020 with an open-market purchase (€4,255) in Mannkind Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to David M. Kendall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Chief Medical OfficerExecutivesMannkind Corp
    5,051 USD33SEC
    4,041 shares@ US$1.2515.5% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-20-044829:0
    Canonical exit: 29 Oct 2020 (T+90)
  • ◆
    Chief Medical OfficerExecutivesMannkind Corp
    22,855 USD22SEC
    15,136 shares@ US$1.5166.8% of flowCommon Stock, $.01 Par ValueSEC:0001209191-20-011689:0
  • ▲
    Chief Medical OfficerExecutivesMannkind Corp
    2,189 USD33SEC
    2,304 shares@ US$0.954.4% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-20-006173:0
    Canonical exit: 30 Apr 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesMannkind Corp
    4,750 USD32SEC
    5,000 shares@ US$0.9510.5% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-19-043926:0
    Canonical exit: 29 Oct 2019 (T+90)
  • ◆
    Chief Medical OfficerExecutivesMannkind Corp
    0SEC
    37,026 shares0Restricted Stock UnitSEC:0001209191-19-012814:0
  • ▲
    Chief Medical OfficerExecutivesMannkind Corp
    5,350 USD30SEC
    5,000 shares@ US$1.0711.4% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-19-006271:0
    Canonical exit: 1 May 2019 (T+90)
  • ◆
    Chief Medical OfficerExecutivesMannkind Corp
    4,998 USD12SEC
    2,824 shares@ US$1.7710.8% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-18-058796:0

7 of 7 declarations